COMPLEMENT REGULATION IN THE RAT GLOMERULUS - CRRY AND CD59 REGULATE COMPLEMENT IN GLOMERULAR MESANGIAL AND ENDOTHELIAL-CELLS

被引:48
|
作者
QUIGG, RJ
MORGAN, BP
HOLERS, VM
ADLER, S
SNEED, AE
LO, CF
机构
[1] UNIV WALES COLL MED,DEPT MED BIOCHEM,CARDIFF CF4 4XN,S GLAM,WALES
[2] UNIV COLORADO,HLTH SCI CTR,DEPT MED,DIV RHEUMATOL,DENVER,CO 80262
[3] NEW YORK MED COLL,DEPT MED,DIV NEPHROL,VALHALLA,NY 10595
[4] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT INTERNAL MED,DIV NEPHROL,RICHMOND,VA 23298
基金
英国惠康基金;
关键词
D O I
10.1038/ki.1995.309
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The complement regulators, decay accelerating factor, membrane cofactor protein, and CD59 are present in human glomeruli. Crry is the rodent analogue to the former two proteins. In this study, we examined complement regulation in cultured rat glomerular endothelial cells (GEnC) and mesangial cells (MES). Immunoprecipitation of I-125-labeled membrane proteins and Western blotting studies were performed with anti-Crry and anti-CD59. In both GEnC and MES, Crry was present as 53, 65, and 78 kD proteins. The 20 kD CD59 was apparent in GEnC. CD59 was, also present in MES, but in relatively smaller quantities. By Northern analyses, 1.8 kb CD59 mRNA was present in GEnC as well as in RNA from isolated rat glomeruli. mRNA for Crry was present in both GEnC and MES as 2.2 kb species. The functional significance of these proteins was evaluated next. Anti-Thy 1.1 IgG was used to activate the complement classical pathway in MES. To inhibit the function of the complement regulators, anti-CD59 and/or anti-Crry F(ab')(2) antibodies were added with anti-Thy 1.1. Inhibition of Crry function led to enhanced cytotoxicity, while there was no effect when CD59 function was inhibited. The complement alternative pathway was studied by adding complement in Mg-EGTA buffer. Inhibition of Crry led to productive alternative pathway activation, which was accentuated by anti-CD59 when Crry was incompletely inhibited. Alternative pathway regulation was also evaluated in GEnC. Inhibition of CD59 function alone had no effect in GEnC, while inhibition of Crry led to significant cytotoxicity from alternative pathway activation. Under conditions in which Crry was inactive, inhibition of CD59 further enhanced cytotoxicity. Therefore, Crry is present in both GEnC and MES and restricts the complement alternative pathway in both cell types. Crry also regulates the classical pathway in MES. CD59 is present and functionally active in GEnC, while it appears to have a minor role in MES.
引用
收藏
页码:412 / 421
页数:10
相关论文
共 50 条
  • [31] Characteristics of CD59 up-regulation induced in porcine endothelial cells by αGal ligation and its association with protection from complement
    Grubbs, BC
    Benson, BA
    Dalmasso, AP
    XENOTRANSPLANTATION, 2003, 10 (05) : 387 - 397
  • [32] CD59 and regulation of terminal complement in hypertensive disorders of pregnancy: The COPA II Study
    Velasquez, Jesus A.
    Burwick, Richard M.
    Silva, Jaime L.
    Lenis, Viviana
    Bernal, Yamile
    Vargas, Johanna
    Valencia, Catalina Maria M.
    Gutierrez, Jorge
    Edna, Francisco
    Trujillo, Juliana
    Rincon, Monica
    Hersh, Alyssa R.
    Tolosa, Jorge E.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S72 - S72
  • [33] KILLING OF RAT GLIAL-CELLS BY COMPLEMENT - DEFICIENCY OF THE RAT ANALOG OF CD59 IS THE CAUSE OF OLIGODENDROCYTE SUSCEPTIBILITY TO LYSIS
    PIDDLESDEN, SJ
    MORGAN, BP
    JOURNAL OF NEUROIMMUNOLOGY, 1993, 48 (02) : 169 - 176
  • [34] REGULATORY CONTROL OF THE TERMINAL COMPLEMENT PROTEINS AT THE SURFACE OF HUMAN ENDOTHELIAL-CELLS - NEUTRALIZATION OF A C5B-9 INHIBITOR BY ANTIBODY TO CD59
    HAMILTON, KK
    JI, Z
    ROLLINS, S
    STEWART, BH
    SIMS, PJ
    BLOOD, 1990, 76 (12) : 2572 - 2577
  • [35] CD59 Regulation by SOX2 Is Required for Epithelial Cancer Stem Cells to Evade Complement Surveillance
    Chen, Jianfeng
    Ding, Peipei
    Li, Ling
    Gu, Hongyu
    Zhang, Xin
    Zhang, Long
    Wang, Na
    Gan, Lu
    Wang, Qi
    Zhang, Wei
    Hu, Weiguo
    STEM CELL REPORTS, 2017, 8 (01): : 140 - 151
  • [36] Variability of glomerular immune deposit, complement membrane attack complex and CD59 in IGA nephropathy.
    Liu, ZH
    Wang, JQ
    Zhou, H
    Yu, YS
    Li, LS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2652 - A2652
  • [37] Regulation of complement receptor (CR1 and CR4) and complement regulating molecules (CD55 and CD59) on leukocytes
    Gritti, D
    Muselli, C
    Malinverno, A
    Ricevuti, G
    MOLECULAR IMMUNOLOGY, 1999, 36 (4-5) : 314 - 314
  • [38] Echovirus infection of rhabdomyosarcoma cells is inhibited by antiserum to the complement control protein CD59
    Goodfellow, IG
    Powell, RM
    Ward, T
    Spiller, OB
    Almond, JW
    Evans, DJ
    JOURNAL OF GENERAL VIROLOGY, 2000, 81 : 1393 - 1401
  • [39] IMMUNOLOCALIZATION AND CHARACTERIZATION OF THE RAT ANALOG OF HUMAN CD59 IN KIDNEY AND GLOMERULAR CELLS
    HUGHES, TR
    MERI, S
    DAVIES, M
    WILLIAMS, JD
    MORGAN, BP
    IMMUNOLOGY, 1993, 80 (03) : 439 - 444
  • [40] RELATIVE ROLES OF DECAY-ACCELERATING FACTOR, MEMBRANE COFACTOR PROTEIN, AND CD59 IN THE PROTECTION OF HUMAN ENDOTHELIAL-CELLS AGAINST COMPLEMENT-MEDIATED LYSIS
    BROOIMANS, RA
    VANWIERINGEN, PAM
    VANES, LA
    DAHA, MR
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (12) : 3135 - 3140